Christopher Causey is Director at UNITED THERAPEUTICS CORP (UTHR). They have made 43 open-market trades across 1 company since 2006, most recently 2026-03-30.
CIK 0001237334
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 43 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 4,190 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-03-30 | 2026-03-31 | $604.64 | $786K | -3.2% | -4.2% | -8.8% |
| UTHR | SELL · 10b5-1 | 2026-03-04 | 2026-03-05 | $490.17 | $10K | +13.0% | +17.1% | +14.9% |
| UTHR | SELL · 10b5-1 | 2026-02-25 | 2026-02-25 | $520.00 | $520K | -0.2% | -1.4% | +9.2% |
| UTHR | SELL · 10b5-1 | 2026-01-06 | 2026-01-06 | $510.00 | $510K | -7.7% | -4.9% | +11.1% |
| UTHR | SELL · 10b5-1 | 2026-01-02 | 2026-01-05 | $500.01 | $500K | -4.7% | -2.5% | +13.1% |
| UTHR | SELL | 2025-09-24 | 2025-09-25 | $440.00 | $440K | +7.0% | -1.4% | +20.6% |
| UTHR | SELL · 10b5-1 | 2025-09-02 | 2025-09-02 | $423.21 | $1.3M | +0.6% | +10.1% | +19.2% |
| UTHR | SELL | 2024-11-01 | 2024-11-04 | $376.63 | $384K | +3.5% | +0.4% | -4.9% |
| UTHR | SELL | 2024-08-21 | 2024-08-22 | $349.00 | $422K | +1.5% | +2.2% | +4.7% |
| UTHR | SELL | 2024-06-18 | 2024-06-20 | $304.18 | $913K | +1.9% | +6.9% | +10.1% |
| UTHR | SELL | 2024-06-13 | 2024-06-14 | $281.53 | $563K | +10.5% | +14.1% | +18.9% |
| UTHR | SELL | 2024-05-15 | 2024-05-16 | $272.90 | $546K | -1.6% | +9.2% | +19.1% |
| UTHR | SELL | 2024-05-03 | 2024-05-06 | $259.91 | $1.2M | +4.1% | +5.9% | +24.6% |
| UTHR | SELL | 2023-12-15 | 2023-12-18 | $255.00 | $102K | -10.6% | -9.7% | -4.9% |
| UTHR | SELL | 2023-12-12 | 2023-12-13 | $249.68 | $749K | -15.9% | -14.8% | -4.0% |
| UTHR | SELL | 2023-01-03 | 2023-01-03 | $276.26 | $276K | -4.2% | -4.8% | -17.3% |
| UTHR | SELL | 2022-11-02 | 2022-11-03 | $250.00 | $1.9M | -2.0% | +3.6% | -1.6% |
| UTHR | SELL | 2022-08-23 | 2022-08-25 | $224.96 | $787K | +0.3% | -8.1% | +20.6% |
| UTHR | SELL | 2022-06-27 | 2022-06-28 | $236.79 | $1.2M | +2.8% | -2.2% | -13.5% |
| UTHR | SELL | 2022-05-26 | 2022-05-26 | $223.64 | $1.3M | +1.2% | +6.6% | -1.6% |
| UTHR | SELL | 2021-08-06 | 2021-08-06 | $210.00 | $548K | -3.0% | -0.8% | -3.9% |
| UTHR | SELL | 2018-09-10 | 2018-09-10 | $119.00 | $96K | +1.9% | +1.7% | -11.0% |
| UTHR | SELL | 2018-09-06 | 2018-09-07 | $118.00 | $96K | +5.8% | +6.4% | -5.2% |
| UTHR | SELL | 2017-12-07 | 2017-12-07 | $134.72 | $156K | -1.4% | +9.0% | -20.0% |
| UTHR | SELL | 2017-11-06 | 2017-11-07 | $122.00 | $71K | +0.8% | +12.3% | +4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.